Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

600276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd.

Trading 10-28 13:57:09

48.86

+3.31

+7.27%

High49.22	Low46.68	Vol132.92M
Open47.00	D1 Closing45.55	Amplitude5.58%
Mkt Cap324.28B	Tradable Cap311.68B	Total Shares6.64B
T/O6.41B	T/O Rate2.08%	Tradable Shares6.38B
P/B4.69	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":48.86,"timestamp":1793167029000,"preClose":45.55,"halted":0,"volume":132918233,"delay":0,"changeRate":0.0727,"floatShares":6379000000,"shares":6637000000,"eps":1.3385,"marketStatus":"Trading","change":3.31,"latestTime":"10-28 13:57:09","open":47,"high":49.22,"low":46.68,"amount":6411000000,"amplitude":0.0558,"askPrice":48.87,"askSize":323,"bidPrice":48.86,"bidSize":15,"shortable":0,"etf":0,"ttmEps":1.3385,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793170800000},"marketStatusCode":2,"adr":0,"adjPreClose":45.55,"symbolType":"stock","openAndCloseTimeList":[[1793151000000,1793158200000],[1793163600000,1793170800000]],"highLimit":50.11,"lowLimit":41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637199874,"isCdr":false,"pbRate":4.69,"roa":"--","peRate":36.503549,"roe":"12.17%","epsLYR":1.19,"committee":-0.247407,"marketValue":324294000000,"turnoverRate":0.0208,"status":0,"hkstockBrief":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":50.1,"timestamp":1793167024050,"preClose":44.72,"halted":0,"volume":12722705,"delay":0,"premium":"-12.87"},"floatMarketCap":311678000000},"requestUrl":"/m/hq/s/600276/wiki","defaultTab":"wiki","newsList":[{"id":"2678431268","title":"Hengrui Presents 64 Oncology Studies at ESMO Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2678431268","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678431268?lang=en_us&edition=fundamental","pubTime":"2026-10-28 12:28","pubTimestamp":1793161702,"startTime":"0","endTime":"0","summary":"Hengrui Presents 64 Oncology Studies at ESMO Congress 2026Hengrui Pharma presented a company-record 64 oncology studies at the ESMO Congress 2026 in Madrid, covering 21 innovative drugs.The research i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL4vxjJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","LU2097828805.USD","LU2148510915.USD","LU1997245177.USD","LU1997244956.HKD","LU1064131003.USD","LU1064130708.USD","LU2580892789.USD","LU2495084118.USD","LU2328871848.SGD","BK0183","BK0188","LU2488822045.USD","LU1328615791.USD","BK0012","LU2097828557.USD","LU1969619763.USD","LU1655091616.SGD","LU1146622755.USD","600276","LU1997245094.SGD","LU2289578879.USD","BK0028","LU1781817850.SGD","LU1820825898.SGD","LU2097828474.EUR","LU2097828714.EUR","BK0239","BK0196","LU1255011170.USD","LU1580142542.USD","BK0060","LU0405327494.USD","LU2580892862.HKD","LU0405327148.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164120933","title":"Hong Kong Pharma Stocks Rally as Strong Q3 Earnings Lift Sector; Hengrui Pharma Jumps Over 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164120933","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164120933?lang=en_us&edition=fundamental","pubTime":"2026-10-28 10:32","pubTimestamp":1793154745,"startTime":"0","endTime":"0","summary":"The third-quarter earnings season is finally stirring the market.On the morning of October 28, Hong Kong's pharmaceutical sector staged a strong rebound, with several companies that had just released...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","LU1023057109.AUD","KURE","LU1146622755.USD","520880","LU2097828557.USD","LU1969619763.USD","LU1328615791.USD","LU0405327494.USD","LU1997245094.SGD","LU2488822045.USD","LU1997244956.HKD","LU1064131003.USD","LU1580142542.USD","BK0239","LU2580892789.USD","LU2097828805.USD","LU1064130708.USD","600276","LU0359201885.HKD","BK0196","BK0060","LU1655091616.SGD","LU2580892862.HKD","BK0183","LU1997245177.USD","LU0359202008.SGD","LU2097828474.EUR","BK1191","LU2097828631.EUR","BK0012","LU2328871848.SGD","LU2148510915.USD","LU0405327148.USD","159718","BK0028","159137","LU2289578879.USD","BK0188","01276","LU1781817850.SGD","LU2543165471.USD","LU1255011170.USD","LU0359201612.USD","LU1820825898.SGD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182678430","title":"CATL Signs MOU with INTILION; Hengrui Pharma's First Three Quarters Net Profit Up 20.38% Year-on-Year; Li Ning Management Plans to Discuss Special Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1182678430","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182678430?lang=en_us&edition=fundamental","pubTime":"2026-10-28 07:43","pubTimestamp":1793144599,"startTime":"0","endTime":"0","summary":"CATL (03750) announced it has signed a memorandum of understanding with European energy storage solutions provider INTILION. Over the next five years, the two parties will deploy 3GWh of CATL's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02331","BK1502","BK1589","LU0823426308.USD","LU0327786744.USD","01276","LU0572944931.SGD","LU2543165471.USD","LU1102505929.USD","LU0359201885.HKD","LU0072462343.USD","82331","BK1512","LU0541501648.USD","LU2125910500.SGD","LU1048588211.SGD","LU1102505762.USD","BK1610","BK1191","LU0359202008.SGD","LU0048580855.USD","600276","LU0593848301.USD","LU0348805143.USD","LU0541502299.USD","LU1023057109.AUD","LU1880383366.USD","LU0370786039.SGD","BK1227","LNNGY","LU0823426480.USD","LU2045819591.USD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678172475","title":"Hengrui Pharma Q3 2026 Net Profit Attributable to Shareholders Jumps 89% to RMB 2.46 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2678172475","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678172475?lang=en_us&edition=fundamental","pubTime":"2026-10-27 20:13","pubTimestamp":1793103229,"startTime":"0","endTime":"0","summary":"Hengrui Pharma Q3 2026 net profit attributable to shareholders jumps 89% to RMB 2.46 billionHengrui Pharma's third-quarter 2026 net profit attributable to shareholders jumped 89% to RMB 2.46 billion; ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nNDLB6yhy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU2580892789.USD","LU1997245177.USD","LU2488822045.USD","LU1064130708.USD","LU1997245094.SGD","LU2148510915.USD","LU1255011170.USD","LU1146622755.USD","BK0196","LU2495084118.USD","LU2097828557.USD","LU1820825898.SGD","LU2097828805.USD","LU0405327494.USD","LU1064131003.USD","LU2289578879.USD","BK0183","LU0405327148.USD","LU1997244956.HKD","LU1655091616.SGD","BK0239","BK0028","LU1969619763.USD","LU2580892862.HKD","LU2097828631.EUR","BK0188","LU1328615791.USD","LU1580142542.USD","LU2097828714.EUR","LU1781817850.SGD","BK0012","LU2097828474.EUR","BK0060","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183881850","title":"Hengrui Pharma Q3: Where Will the Next Wave of Growth Come From?","url":"https://stock-news.laohu8.com/highlight/detail?id=1183881850","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183881850?lang=en_us&edition=fundamental","pubTime":"2026-10-27 19:54","pubTimestamp":1793102087,"startTime":"0","endTime":"0","summary":"In 2026, China's innovative drug industry is steadily entering a new phase of translating innovation into commercial results.Data from the National Medical Products Administration show that 76...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK1191","LU2543165471.USD","LU1580142542.USD","LU1255011170.USD","LU1328615791.USD","LU2289578879.USD","LU1820825898.SGD","BK0060","LU0405327494.USD","LU2097828474.EUR","BK0028","600276","LU2097828805.USD","LU2097828557.USD","LU1997244956.HKD","LU2097828714.EUR","LU0359201885.HKD","LU1064130708.USD","LU2488822045.USD","LU1146622755.USD","BK0239","BK0196","LU0405327148.USD","LU1997245094.SGD","LU0359202008.SGD","LU1969619763.USD","LU2097828631.EUR","BK0188","LU1997245177.USD","LU2580892789.USD","LU1655091616.SGD","LU2580892862.HKD","LU1064131003.USD","LU2328871848.SGD","LU2495084118.USD","01276","LU2148510915.USD","BK0183","LU1023057109.AUD","LU0359201612.USD","LU1781817850.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678120974","title":"Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2678120974","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678120974?lang=en_us&edition=fundamental","pubTime":"2026-10-27 18:04","pubTimestamp":1793095471,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nTUA2RQTDR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["600276","LU1969619763.USD","LU2328871848.SGD","LU0405327148.USD","LU2580892862.HKD","LU0405327494.USD","BK0012","LU2097828805.USD","LU1064130708.USD","LU2097828557.USD","LU1997244956.HKD","LU1064131003.USD","LU1328615791.USD","LU1655091616.SGD","LU2097828631.EUR","LU1820825898.SGD","BK0183","BK0196","LU1781817850.SGD","LU2488822045.USD","LU1997245094.SGD","LU1255011170.USD","LU2097828714.EUR","BK0028","LU2580892789.USD","LU1997245177.USD","BK0060","LU1146622755.USD","BK0239","LU2148510915.USD","LU2495084118.USD","LU1580142542.USD","LU2289578879.USD","BK0188","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678277691","title":"JPMorgan Chase & Co's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 9.74% on Oct 22 from 10.26% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2678277691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678277691?lang=en_us&edition=fundamental","pubTime":"2026-10-27 17:56","pubTimestamp":1793094994,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nFWN46D0P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0183","LU1655091616.SGD","BK0188","LU1146622755.USD","LU1064131003.USD","LU0359201612.USD","LU0359201885.HKD","BK0196","LU0405327148.USD","LU2488822045.USD","BK1191","LU2097828805.USD","BK0012","600276","LU2097828714.EUR","LU2097828631.EUR","LU2289578879.USD","LU1820825898.SGD","BK0060","LU1023057109.AUD","LU1997244956.HKD","LU2580892789.USD","BK0028","BK0239","LU2495084118.USD","LU2097828557.USD","LU2148510915.USD","LU2328871848.SGD","LU1997245177.USD","LU2543165471.USD","LU1064130708.USD","LU1255011170.USD","LU1997245094.SGD","LU1580142542.USD","LU1969619763.USD","LU0405327494.USD","LU2097828474.EUR","LU1328615791.USD","LU0359202008.SGD","LU2580892862.HKD","LU1781817850.SGD","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125365924","title":"HENGRUI PHARMA's Class 1 Innovative Drug Remimazolam Tosilate for Injection Gains Approval for New Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1125365924","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125365924?lang=en_us&edition=fundamental","pubTime":"2026-10-27 17:48","pubTimestamp":1793094497,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has issued an announcement stating that Jiangsu Hengrui Pharmaceuticals Co.,Ltd. recently received notification from the National Medical Products Administration approving a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU1997245177.USD","LU1655091616.SGD","LU2097828805.USD","LU1580142542.USD","LU1997244956.HKD","LU2543165471.USD","LU2580892789.USD","BK1574","LU2495084118.USD","600276","MEDX","LU2097828631.EUR","01276","LU0359202008.SGD","LU2097828474.EUR","LU0359201612.USD","LU1820825898.SGD","LU0405327494.USD","06978","BK0183","BK0012","LU2289578879.USD","LU1023057109.AUD","LU2097828714.EUR","LU1064130708.USD","BK1161","BK0239","159992","LU2097828557.USD","LU2488822045.USD","BK0188","LNGR","LU1969619763.USD","BK1191","LU1255011170.USD","BK0196","LU1781817850.SGD","LU2328871848.SGD","IBBQ","BK0028","LU1064131003.USD","BK0060","LU1328615791.USD","LU0405327148.USD","LU2148510915.USD","LU0359201885.HKD","LU1146622755.USD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678312792","title":"Jiangsu Hengrui Pharmaceuticals Co Ltd - Nmpa Approved Additional Indication for Remimazolam Tosilate for Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2678312792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678312792?lang=en_us&edition=fundamental","pubTime":"2026-10-27 17:44","pubTimestamp":1793094298,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nFWN46D0RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2580892862.HKD","LU1997245177.USD","LU1655091616.SGD","LU2097828805.USD","LU1580142542.USD","LU1997244956.HKD","LU2543165471.USD","LU2580892789.USD","LU2495084118.USD","600276","LU2097828631.EUR","01276","LU0359202008.SGD","LU2097828474.EUR","LU0359201612.USD","LU1820825898.SGD","LU0405327494.USD","BK0183","BK0012","LU2289578879.USD","LU1023057109.AUD","LU2097828714.EUR","LU1064130708.USD","BK0239","LU2097828557.USD","LU2488822045.USD","BK0188","LU1969619763.USD","BK1191","LU1255011170.USD","BK0196","LU1781817850.SGD","LU2328871848.SGD","BK0028","LU1064131003.USD","BK0060","LU1328615791.USD","LU0405327148.USD","LU2148510915.USD","LU0359201885.HKD","LU1146622755.USD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678211241","title":"Jiangsu Hengrui Pharmaceuticals Q3 Net Profit up 88.9% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2678211241","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678211241?lang=en_us&edition=fundamental","pubTime":"2026-10-27 16:43","pubTimestamp":1793090638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nL3N46D0NT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2097828805.USD","LU2097828557.USD","BK0028","LU1064131003.USD","LU1997245177.USD","LU1064130708.USD","LU1255011170.USD","LU1997245094.SGD","LU2328871848.SGD","LU1997244956.HKD","LU2289578879.USD","LU2097828631.EUR","LU2495084118.USD","LU1328615791.USD","BK0188","LU2148510915.USD","BK0060","LU1655091616.SGD","LU2488822045.USD","LU2580892789.USD","BK0183","600276","BK0196","BK0239","LU1146622755.USD","LU2097828714.EUR","LU2097828474.EUR","LU1820825898.SGD","LU0405327494.USD","LU0405327148.USD","LU1580142542.USD","LU1781817850.SGD","LU1969619763.USD","BK0012","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157159241","title":"HENGRUI PHARMA Reports Nine-Month Net Profit of RMB 6.923 Billion, Up 20.38% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1157159241","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157159241?lang=en_us&edition=fundamental","pubTime":"2026-10-27 16:36","pubTimestamp":1793090174,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has released its results for the first three quarters of 2026, reporting revenue of approximately RMB 24.409 billion, an increase of 5.26% year-on-year.Net profit attributable...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359202008.SGD","LU2580892789.USD","LU2580892862.HKD","LU1969619763.USD","LU2148510915.USD","LU2097828631.EUR","LU2097828557.USD","LU1023057109.AUD","LU2328871848.SGD","BK0012","LU1997245094.SGD","LU2289578879.USD","LU1064131003.USD","LU0405327494.USD","BK1191","LU2488822045.USD","BK0028","LU1997244956.HKD","01276","BK0060","600276","BK0196","LU0359201612.USD","LU1328615791.USD","LU0405327148.USD","LU1580142542.USD","LU2097828805.USD","LU1997245177.USD","LU2097828714.EUR","LU1146622755.USD","BK0239","LU2097828474.EUR","LU2543165471.USD","LU1655091616.SGD","BK0183","LU1064130708.USD","LU1255011170.USD","LU0359201885.HKD","BK0188","LU1781817850.SGD","LU1820825898.SGD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678812135","title":"Jiangsu Hengrui Pharmaceuticals 9M Revenue RMB 24,408.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2678812135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678812135?lang=en_us&edition=fundamental","pubTime":"2026-10-27 16:32","pubTimestamp":1793089956,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nPLXK51F9L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2097828557.USD","LU1146622755.USD","LU0405327494.USD","LU2289578879.USD","LU1064130708.USD","LU1255011170.USD","LU1997244956.HKD","600276","LU2495084118.USD","LU2488822045.USD","LU0405327148.USD","LU1997245094.SGD","LU1997245177.USD","LU2580892862.HKD","LU1328615791.USD","LU1969619763.USD","LU1820825898.SGD","LU2097828631.EUR","BK0012","LU2097828474.EUR","LU2580892789.USD","BK0183","LU1064131003.USD","BK0060","LU1580142542.USD","LU1655091616.SGD","LU2148510915.USD","LU2328871848.SGD","LU2097828714.EUR","BK0239","LU2097828805.USD","LU1781817850.SGD","BK0188","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116085775","title":"AH Premium Statistics for October 26: Northeast Electric Tops Premium Rankings","url":"https://stock-news.laohu8.com/highlight/detail?id=1116085775","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116085775?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:24","pubTimestamp":1793003075,"startTime":"0","endTime":"0","summary":"According to data as of the market close on October 26, NE ELECTRIC (00042), Zhejiang Shibao Company Limited (01057), and Triumph New Energy Company Limited (01108) ranked as the top three in AH...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","01919","LU1303224171.USD","BK1521","LU2543165471.USD","LU0326950275.SGD","600276","LU0043850808.USD","IE00B3M56506.USD","LU0918141705.HKD","LU1105468828.SGD","LU2097828474.EUR","LU0164880469.USD","HK0000306701.USD","603083","BK1554","LU0456854461.SGD","LU0979878070.USD","SG9999002828.SGD","IE0008369823.USD","603341","LU0531971595.HKD","09607","LU0791591158.USD","BK1514","BK1202","BK1610","BK1170","LU1282649141.HKD","LU0463099449.HKD","LU0315179316.USD","IE0008368742.USD","06185","LU0737861699.HKD","LU0868486357.SGD","600775","605499","LU0348816934.USD","03986","LU2242644610.SGD","601899","LU0106959298.USD","LU1993786604.SGD","06869","LU0345780521.USD","LU0359201612.USD","BK1140","LU0067412154.USD","LU0417516902.SGD","LU0228367735.SGD","IE00BYV24P56.USD","LU0181495838.USD","LU2097828714.EUR","09611","LU1211504680.USD","LU3063872942.SGD","688185","BK1503","LU0106252389.USD","BK1147","03968","LU0359201885.HKD","BK1240","600036","LU1152091168.USD","02009","LU0173614495.USD","LU0791590937.USD","002703","BK1110","LU2097828631.EUR","LU2399975544.HKD","SG9999002463.SGD","BK1223","IE00B543WZ88.USD","LU2097828557.USD","LU0348825331.USD","LU0163747925.USD","LU0469268626.HKD","LU0589944569.HKD","BK1583","000488","LU0384037296.USD","LU1152091754.HKD","LU0345780281.USD","LU2045819591.USD","LU0228659784.USD","IE00B0169L03.USD","LU0029875118.USD","LU0348767384.USD","02899","LU0455707207.USD","BK1523","BK1103","688505","000338","LU1688375341.USD","HK0000352291.HKD","LU2177674079.SGD","IE00BZ08YR35.GBP","LU2039709279.SGD","IE00BVYPNP33.GBP","LU1242518857.USD","LU0210526637.USD","01057","BK1576","600860","IE00B031HY20.USD","BK1526","LU0593848301.USD","003021","LU0327786744.USD","LU0572944931.SGD","LU0348827113.USD","LU0737861772.HKD","LU0797268264.HKD","BK1551","BK1544","06613","LU0117841782.USD","LU0828237510.HKD","LU0049853897.USD","BK1515","LU0287142896.SGD","LU0821914370.USD","688981","LU1880383366.USD","LU1961090484.USD","LU0061477393.USD","LU0266512127.USD","02359","BK1122","01812","01276","000333","LU1807302812.USD","LU1282649067.USD","00187","BK1563","BK1193","LU0634319403.HKD","LU2294711473.HKD","BK1214","LU0672654166.SGD","LU1366334651.USD","LU0531970944.HKD","02338","LU0266512473.USD","IE0032431581.USD","LU0886674414.USD","02692","300433","00719","LU1794554557.SGD","LU0516422440.USD","IE00BZ08YT58.USD","LU0039217434.USD","01349","IE00BF5LJ272.USD","LU0214875030.USD","CIHKY","LU0648948544.HKD","03268","LU0823426308.USD","LU1960683339.HKD","BK1144","LU0082770016.SGD","LU0149534421.HKD","LU1255011170.USD","01330","LU0269904917.USD","300750","BK1163","LU0082770016.USD","BK1183","LU1242518931.SGD","BK1522","IE00BZ08YS42.EUR","LU0456827905.SGD","00553","LU1504937902.USD","LU0149721374.USD","BK1537","LU0051755006.USD","LU0516422952.EUR","LU1675838814.USD","LU0348788117.USD","LU1988902786.USD","LU0588546209.SGD","BK1198","SEA","LU0516422366.SGD","LU0254981946.USD","LU0918141887.USD","BK1592","LU2476274308.USD","HK0000320223.HKD","002881","LU1831875114.USD","LU1328277881.USD","IE00BVYPNQ40.USD","BK1149","LU1206782309.USD","LU1251922891.USD","06745","LU1008478684.HKD","LU1813983027.USD","LU2394011477.USD","601869","IE00BGHQDM52.EUR","LU0096374516.USD","BK1141","BK1614","LU1769817096.USD","IE0034224299.USD","LU1481107354.HKD","BK1560","LU0880133367.SGD","02245","LU0244354667.USD","LU0502904849.HKD","002865","LU2125910500.SGD","SG9999011746.SGD","LU1188198961.HKD","SG9999001440.SGD","LU0164865239.USD","LU2264538146.SGD","SG9999014674.SGD","LU0307460666.USD","LU0359202008.SGD","BK1116","LU0890818403.SGD","LU1282649810.SGD","LU0607220059.USD","601330","LU0871576103.HKD","LU0823426480.USD","LU1244550577.SGD","LU0449509016.USD","BK1505","02865","BK1535","BK1249","LU1770034418.SGD","LU1282648689.USD","LU1655091616.SGD","603259","LU0052750758.USD","603986","BBMPY","LU1244550221.USD","LU0348735423.USD","BK1594","BK1564","LU0320764599.SGD","LU0328353924.USD","LU0048580855.USD","00981","BK1562","LU1224709979.USD","BK1231","LU1366334578.USD","03750","09980","LU0320764755.SGD","LU0370786039.SGD","LU1226287529.USD","LU0862451753.SGD","BK1135","03143","300308","BK1507","BK1105","LU2008162690.USD","603650","600876","BK1161","LU0417516738.SGD","IE00B5MMRT66.SGD","LU0509642566.USD","LU1046422090.SGD","001236","LU0828238088.HKD","LU0516423174.USD","BK1190","IE00B031J352.USD","LU0620787316.HKD","LU1769817179.HKD","BK1574","LU0516423091.SGD","LU0165289439.USD","000756","LU0640798160.USD","LU0140636845.USD","LU0456846285.SGD","601678","03678","BK1533","LU0708995583.HKD","LU0561508036.HKD","LU0348814723.USD","HK0000320264.USD","LU2097828805.USD","600871","IE0031814852.USD","LU0431992006.USD","LU0211977185.USD","000513","BK1506","BK1546","LU0128522157.USD","LU0828237940.HKD","LU0543330483.HKD","LU0329678337.USD","LU0543330566.HKD","LU0348766576.USD","03308","LU1048596156.SGD","LU1115378108.SGD","LU0229945570.USD","01033","LU0488056044.USD","LU0329678170.USD","LU0314109678.HKD","LU0501845795.SGD","BK1200","HK0000352382.USD","LU1720050803.USD","LU0348805143.USD","ZIJMY","SG9999006597.SGD","06166","601919","601992","LU1064131342.USD","LU0231483743.USD","01513","LU1244550494.USD","00300","BK1171","IE00BMCWC346.EUR","LU1719994722.HKD","HK0000306685.HKD","LU1023057109.AUD","00042","LU1880383440.USD","01108","LU2226246903.HKD","IE00B29SXG58.USD","LU1808992512.USD","BK1191","LU2476274720.SGD","LU0072913022.USD","SG9999004220.SGD","LU0540923850.HKD","LU0164939612.USD","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150822607","title":"New Growth Drivers Take Center Stage as China's Economy Accelerates","url":"https://stock-news.laohu8.com/highlight/detail?id=1150822607","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150822607?lang=en_us&edition=fundamental","pubTime":"2026-10-25 18:01","pubTimestamp":1792922468,"startTime":"0","endTime":"0","summary":"Since the beginning of this year, China's new growth drivers have been rapidly expanding, playing an increasingly strong role in fueling the economy.Data from the National Development and Reform...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0455707207.USD","LU2328871848.SGD","LU0326950275.SGD","LU0502904849.HKD","LU2580892789.USD","BK1589","LU0244354667.USD","LU1146622755.USD","BK0012","LU2242644610.SGD","BK0183","LU1997245177.USD","LU2289578879.USD","LU1969619763.USD","LU0405327148.USD","BK1583","LU1064130708.USD","LU1328615791.USD","LU1064131003.USD","BK0188","LU0463099449.HKD","LU1255011170.USD","LU2097828805.USD","LU1580142542.USD","BK0196","LU1781817850.SGD","BK0060","LU2148510915.USD","01801","LU2495084118.USD","BK0028","BK1161","LU2488822045.USD","LU2097828631.EUR","BK0239","KURE","HK0000165453.HKD","LU2097828714.EUR","LU1188198961.HKD","LU1655091616.SGD","LU0149534421.HKD","LU2097828474.EUR","01276","LU0405327494.USD","LU0607220059.USD","600276","LU1820825898.SGD","LU1997244956.HKD","LU1997245094.SGD","LU2097828557.USD","LU2580892862.HKD","LU1831875114.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677913256","title":"Hengrui Pharma Gets China Nod For Phase 3 Trial of Prostate Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2677913256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677913256?lang=en_us&edition=fundamental","pubTime":"2026-10-23 09:00","pubTimestamp":1792717253,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals (SHA:600276, HKG:1276) received approval from China's National Medical Products Administration to conduct a Phase III clinical trial of rezvilutamide tablets, according","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2097828714.EUR","LU1023057109.AUD","LU1146622755.USD","LU2097828557.USD","LU1969619763.USD","LU1328615791.USD","LU0405327494.USD","LU1997245094.SGD","LU2488822045.USD","LU1997244956.HKD","LU1064131003.USD","LU1580142542.USD","BK0239","LU2580892789.USD","LU2097828805.USD","LU1064130708.USD","600276","LU0359201885.HKD","BK0196","BK0060","LU1655091616.SGD","LU2580892862.HKD","BK0183","LU1997245177.USD","LU0359202008.SGD","LU2097828474.EUR","BK1191","LU2097828631.EUR","BK0012","LU2328871848.SGD","LU2148510915.USD","LU0405327148.USD","BK0028","LU2289578879.USD","BK0188","01276","LU1781817850.SGD","LU2543165471.USD","LU1255011170.USD","LU0359201612.USD","LU1820825898.SGD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677597189","title":"Jiangsu Hengrui Files HKEX Next Day Disclosure Return Announcing Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2677597189","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677597189?lang=en_us&edition=fundamental","pubTime":"2026-10-22 18:15","pubTimestamp":1792664156,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Files HKEX Next Day Disclosure Return Announcing Share BuybackJiangsu Hengrui Medicine repurchased 150,000 A shares on October 22, 2026, for RMB 6.92 million.Repurchase prices ranged f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nNDL24TzBd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","BK0060","LU1781817850.SGD","LU2097828631.EUR","LU1580142542.USD","LU2148510915.USD","LU2580892862.HKD","LU1820825898.SGD","LU2097828557.USD","LU2495084118.USD","LU2580892789.USD","LU1997244956.HKD","BK0183","BK0239","BK0028","LU1064130708.USD","LU2097828474.EUR","BK0188","LU1328615791.USD","LU0405327494.USD","LU1655091616.SGD","LU1997245094.SGD","LU2488822045.USD","LU2289578879.USD","LU1997245177.USD","LU2097828714.EUR","LU1255011170.USD","LU1969619763.USD","BK0196","600276","BK0012","LU0405327148.USD","LU2097828805.USD","LU1064131003.USD","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676566381","title":"Hengrui Pharma's 64 Oncology Research Findings Accepted for ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2676566381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676566381?lang=en_us&edition=fundamental","pubTime":"2026-10-20 16:09","pubTimestamp":1792483773,"startTime":"0","endTime":"0","summary":"Hengrui Pharma's 64 Oncology Research Findings Accepted for ESMO 2026Hengrui Pharma will present 64 research findings at the ESMO Congress in Madrid, October 23-27, 2026.Phase 3 HORIZON-Breast06 findi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL1R0JxG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0188","LU2097828714.EUR","LU2097828631.EUR","LU2580892789.USD","BK0196","LU2328871848.SGD","LU1580142542.USD","LU1997245177.USD","LU2148510915.USD","BK0012","600276","LU1064130708.USD","LU0405327148.USD","LU2488822045.USD","BK0028","LU2097828474.EUR","LU2580892862.HKD","BK0060","LU1255011170.USD","LU1997245094.SGD","LU1820825898.SGD","LU2097828557.USD","LU2097828805.USD","LU1655091616.SGD","LU1064131003.USD","LU1969619763.USD","LU1328615791.USD","LU1997244956.HKD","LU2495084118.USD","LU2289578879.USD","LU1146622755.USD","LU1781817850.SGD","BK0239","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676897746","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2676897746","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676897746?lang=en_us&edition=fundamental","pubTime":"2026-10-19 21:37","pubTimestamp":1792417073,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 19 (Reuters)-Swiss drugmaker RocheROPC.Sentered a collaboration and licensing agreement withChina'sHansoh3692.HK, in a deal that could exc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nL4N46511Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2602419157.SGD","LU1983299246.USD","VHT","IE00BKDWB100.SGD","LU1629891620.HKD","LU0238689110.USD","LU2580892789.USD","LU0471298694.HKD","SG9999014898.SGD","LU0417517546.SGD","SG9999014906.USD","LU1093756325.SGD","LU2417539215.USD","LU0823434583.USD","PJP","LU0708995401.HKD","LU0823416689.USD","IHE","IE00B7KXQ091.USD","AGNG","IE00BJJMRZ35.SGD","BK0239","IE00BKPKM429.USD","BK4007","IE0001KFT4U8.USD","LU1023059063.AUD","LU2112291526.USD","IE0005OL40V9.USD","SGXZ99366536.SGD","LU2471134952.CNY","LU1814569148.SGD","LU1655091616.SGD","LU1969619763.USD","MEDI","LU0683600562.USD","LU0096364046.USD","BK4581","LU1580142542.USD","LU2211817866.USD","LU2328871848.SGD","LU2023250330.USD","LU2237443465.HKD","LLII","LU0061475181.USD","LU0289739699.SGD","LU1146622755.USD","LU2108987350.USD","LU2168564065.EUR","IE00BJLML261.HKD","HRTS","LU0158827948.USD","LU2456880835.USD","LU1551013425.SGD","PPH","SG9999018857.SGD","LU1720051108.HKD","LU0432979614.USD","LU2468319806.SGD","IE00BK4W5L77.USD","LU1057294990.SGD","LU1291159041.SGD","LU2237443622.USD","CANC","IE00BJT1NW94.SGD","IE00B1XK9C88.USD","LU1127390331.HKD","LU2896262040.SGD","IE00BJJMRY28.SGD","LU0323591593.USD","LU0316494557.USD","LU2552382215.SGD","IE00BFSS7M15.SGD","LU0174119429.USD","LU1974910355.USD","IE0009355771.USD","LU2495084118.USD","LU0006306889.USD","IE00BJJMRX11.SGD","GB00BDT5M118.USD","LU2023251221.USD","LU0094547139.USD","BK4534","SG9999001176.SGD","LU1064131342.USD","LU2756315318.SGD","LU2089283258.USD","MHIP","JDOC","LU0882574139.USD","IE00BFSS8Q28.SGD","LU0466842654.USD","LU2491049909.HKD","SG9999014914.USD","LU2023250504.SGD","LU1255011170.USD","IE0004445239.USD","LU1035775433.USD","LU1720051017.SGD","LU0786609619.USD","LU2271345857.HKD","LU1551013342.USD","LU0345770993.USD","ILDR","GDOC","LU0964807845.USD","LU1623119135.USD","LU0058720904.USD","LU0158827781.USD","LU2491050071.SGD","SG9999013999.USD","LU0133085943.USD","SG9999015978.USD","BK0183","LU1153585028.USD","LU1145028129.USD","LU0097036916.USD","LU2488822045.USD","600276","LU0882574055.USD","LU2213496289.HKD","LU0820561909.HKD","LU1328615791.USD","IYH","LU2491050154.USD","LU1997245177.USD","LU2361044865.SGD","LU0234572021.USD","LU1988902786.USD","ELIL","LU2236285917.USD","BK4588","LU0114720955.EUR","LU1917777945.USD","LU2063271972.USD","LU2237443382.USD","CURE","IE00BFTCPJ56.SGD","LU2471134879.HKD","OZEM","LU2168564149.EUR","LU2462591350.SGD","XLV","LU1548497426.USD","LU2028103732.USD","IE00B775H168.HKD","LU0345770308.USD","LU2264538146.SGD","LU0011850046.USD","LU2462157665.USD","BK0060","IE00B4R5TH58.HKD","LU2552382132.HKD","LU0471298777.SGD","BK4585","SGXZ51526630.SGD","LU2324357040.USD","LU1712237335.SGD","LU2471134523.USD","LU1064131003.USD","LU1093756168.USD","LLYZ","LU0456855351.SGD","LU2087625088.SGD","LU0787776722.HKD","LU0109391861.USD","LU0385154629.USD","SG9999017495.SGD","LU0225283273.USD","LU1280957306.USD","LU2357305700.SGD","LU0320765992.SGD","BK0196","SGXZ57979304.SGD","IE00BK4W5M84.HKD","LU1804176565.USD","LU1267930730.SGD","LU0640476718.USD","LU0354030438.USD","LU0256863902.USD","IE00B1BXHZ80.USD","LU0405327148.USD","LU0198837287.USD","LU2360106947.USD","LU1781817850.SGD","FHLC","LU2361044949.HKD","LU2125154778.USD","LU2361045086.USD","LU2756315664.SGD","SG9999015945.SGD","LU2148510915.USD","01276","LU1820825898.SGD","BK4533","THNR","LU1868836914.USD","TMED","LU0203201768.USD","LU0354030511.USD","IE0004445015.USD","WDNA","BK0188","LU2089284900.SGD","ELIS","LU2125154935.USD","IXJ","SG9999015952.SGD","LU0672654240.SGD","LU1868836757.USD","SGXZ81514606.USD","LU0203202063.USD","LU1868837300.USD","LU1232071149.USD","LU2097828474.EUR","LU0109394709.USD","LU1366192091.USD","LU0320765059.SGD","LU2289578879.USD","LU2461242641.AUD","SG9999018865.SGD","LU2097828805.USD","LU0823434740.USD","LU0106261372.USD","LU2360032135.SGD","LU2106854487.HKD","LU0266013472.USD","LLYX","SG9999014880.SGD","LU2750360641.GBP","IE00BN29S564.USD","LU0079474960.USD","IE00B4JS1V06.HKD","LLY","LU2168564222.USD","LU2265009873.SGD","LU2746668461.USD","BK0012","LU2237438978.USD","LU2471134796.USD","LU0353189680.USD","LU0889565916.HKD","LU1323610961.USD","LU2097828714.EUR","LU1061106388.HKD","LU2089984988.USD","LU2168563687.JPY","LU2237443549.SGD","LU2746668974.SGD","LU1979441026.SGD","TRUH","LU2552382058.USD","BK4599","SG9999015986.USD","BK4516","LU2097828557.USD","LU0820561818.USD","LU1868836591.USD","BK0028","LU1997245094.SGD","LU0256863811.USD","FTXH","LU0353189763.USD","MEDX","LU2111349929.HKD","LU2237443895.HKD","RXL","LU1989771016.USD","LU2750360997.AUD","LU0210536198.USD","SGXZ31699556.SGD","LU2580892862.HKD","LU0943347566.SGD","LU2097828631.EUR","SG9999001176.USD","LU1691799644.USD","LU1069344957.HKD","LU0820562030.AUD","LU2211815571.USD","LU2237443978.SGD","IE00BWXC8680.SGD","LU1997244956.HKD","LU0122379950.USD","LU0405327494.USD","LU0689472784.USD","IE0002141913.USD","IE00B2B36J28.USD","LU1064130708.USD","LU2168564495.EUR","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676500927","title":"China's Hansoh Pharma Strikes Drug Deal with Roche Worth over $15 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2676500927","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676500927?lang=en_us&edition=fundamental","pubTime":"2026-10-19 18:58","pubTimestamp":1792407499,"startTime":"0","endTime":"0","summary":"UPDATE 2-China's Hansoh Pharma strikes drug deal with Roche worth over $15 billionOct 19 (Reuters)-China's Hansoh Pharmaceutical3692.HKsaid on Monday it has entered into a partnership and licensing de","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nL4N4650QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","LU0868494617.USD","LU2097828474.EUR","IE0002141913.USD","LU0061475181.USD","LU2125154935.USD","GPCR","600276","LU0321505868.SGD","LU1236620750.USD","LU2495084118.USD","LU2242646821.SGD","LU2328871848.SGD","LU1718418525.SGD","LU0225771236.USD","LU1064131003.USD","IE00BFXG1179.USD","LU1323610961.USD","FTXH","LU1868837300.USD","LU1781817850.SGD","LU0432979614.USD","LU1064130708.USD","BK4581","LU1670710661.SGD","03692","LU1868836914.USD","LU0405327494.USD","LU0456855351.SGD","LU2133065610.SGD","LU2360032135.SGD","LU1969619763.USD","BK0188","LU0405327148.USD","IHE","BK4532","LU1997245094.SGD","LU1328615791.USD","BK4599","BK0196","LU1261432733.SGD","BK0060","BK1191","LU2097828557.USD","IE00BFTCPJ56.SGD","BK0028","BK1589","LU0985481810.HKD","LU2289578879.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676502440","title":"Jiangsu Hengrui Medicine Files HKEX Next-Day Disclosure on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2676502440","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676502440?lang=en_us&edition=fundamental","pubTime":"2026-10-19 18:09","pubTimestamp":1792404576,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Medicine Files HKEX Next-Day Disclosure on Share BuybackJiangsu Hengrui Medicine repurchased 203,600 A shares on October 19, 2026, for RMB 9.4 million.Repurchase prices ranged from RMB","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nNDLc8TTxC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","600276","LU1997245094.SGD","LU1655091616.SGD","LU2580892789.USD","LU2289578879.USD","LU1969619763.USD","BK0239","LU1997244956.HKD","LU1328615791.USD","LU1997245177.USD","LU2097828631.EUR","BK0196","LU1580142542.USD","LU1781817850.SGD","BK0060","LU2328871848.SGD","LU2097828714.EUR","LU2148510915.USD","LU1064130708.USD","LU0405327494.USD","LU1064131003.USD","LU2488822045.USD","LU1255011170.USD","LU2097828805.USD","LU1820825898.SGD","LU2495084118.USD","BK0183","LU0405327148.USD","LU2097828474.EUR","BK0012","LU2580892862.HKD","LU1146622755.USD","LU2097828557.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793167031098,"stockEarnings":[{"period":"1week","weight":-0.04},{"period":"1month","weight":0.0154},{"period":"3month","weight":-0.1548},{"period":"6month","weight":-0.1511},{"period":"1year","weight":-0.3175},{"period":"ytd","weight":-0.2322}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.0471},{"period":"6month","weight":-0.1128},{"period":"1year","weight":-0.0872},{"period":"ytd","weight":-0.0808}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"江苏恒瑞医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"604325人(较上一季度增加12.09%)","perCapita":"10555股","listingDate":"2000-10-18","address":"江苏省连云港市连云区经济技术开发区黄河路38号","registeredCapital":"663719万元","survey":"　　江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是注射用卡瑞利珠单抗、羟乙磺酸达尔西利片、瑞维鲁胺片、海曲泊帕乙醇胺片、脯氨酸恒格列净片、碘佛醇注射液。","listedPrice":11.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.,600276,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎国际,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股价,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股市,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票价格,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票交易,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票购买,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction